Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
  1. Home
  2. Search

Refine search

Refine search

Access:
Content type:
Publication date:
Apply   From and To filters
Subject: Show more
Journals Show more
Publishers: Show more
Societies Show more
Series: Show more
Collections: Show more

Actions for selected content:

Select all | Deselect all
  • View selected items
  • Export citations
  • Download PDF (zip)
  • Save to Kindle
  • Save to Dropbox
  • Save to Google Drive

Save Search

You can save your searches here and later view and run them again in "My saved searches".

Please provide a title, maximum of 40 characters.
Cancel
×

1 results

  • Chapter 14 - REM sleep behavior disorder

  • from Section 3 - Parasomnias usually associated with REM sleep
  • Edited by Michael J. Thorpy, Giuseppe Plazzi, Università di Bologna
  • Book:
    The Parasomnias and Other Sleep-Related Movement Disorders
    Published online:
    10 November 2010
    Print publication:
    10 June 2010, pp 131-141

  • Summary

    Sleepwalking is not the only NREM parasomnia that has been observed to be associated with medication or substance. It is, however, the most common group, the one most familiar to psychiatrists, who noted this as a side effect following initiation or escalation of some medications used for treating their patients, particularly those with bipolar depression in manic episodes, schizoaffective patients and anxiety patients with insomnia. This chapter covers the published reports in which sleepwalking event occurred closely following the initiation of medication and its resolution on withdrawal from the drug. The anti-depressant medications and their effects on sleep, few studies give the effects on slow-wave sleep (SWS). The benzodiazepine that has been most clearly associated with sleep-related eating disorder (SRED) is triazolam, although it is associated with initiation of several other NREM parasomnias.